Ilaria Dicembrini is an expert in Endocrinology at University of Florence (Italy). As of November 2026, ScienceLeadR ranks Ilaria Dicembrini in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Ilaria Dicembrini has authored 106 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 353 (community average: 125). How the SLR is computed.

LeadR Profile

Ilaria Dicembrini University of Florence Italy
353 ScienceLeadR Reputation 353
Network Map

Endocrinology

Subspecialties: Nutrition - Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

University of Florence

2011 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 106

Citations

Citations: 3 997 1st author: 23 Last author: 8 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Optimizing the use of the Omnipod 5 system in adults with type 1 diabetes: an Italian expert Delphi consensus.
PMID 42772375 — diabetes mellitus, exercise, hyperglycemia, meals, hypoglycemia, diabetes mellitus, type 1
Diabetes Res Clin Pract20260
Cross-cultural adaptation, validation, and measurement invariance of the Italian version of the diabetes health literacy scale among Italian-born and foreign-born adults with type 2 diabetes mellitus.
PMID 42497961 — diabetes mellitus, research design, health literacy, literacy, diabetes mellitus, type 2
Diabetes Res Clin Pract20260
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown.
PMID 41803464 — diabetes mellitus, glucagon-like peptide 1, glucagon-like peptide-1 receptor, neoplasms, obesity, glucagon, therapeutics, glucagon-like peptides, diabetes mellitus, type 2
Nat Rev Clin Oncol Top journal20262
Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal-bolus insulin therapy: A randomised controlled trial.
PMID 41582725 — diabetes mellitus, safety, insulin, nursing, telemedicine, home nursing, nursing homes, therapeutics, diabetes mellitus, type 2, nursing home residents
Diabetes Obes Metab20260
Efficacy, safety, and legal considerations of do-it-yourself artificial pancreas systems: a position statement from italian diabetes societies.
PMID 40773023 — diabetes mellitus, pancreas, artificial, safety, pancreas, software
Acta Diabetol20250

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2

By status:

Completed 2

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map